연구동향 분석

Invited Mini Review : Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases

( Eun Hye Lee ) ( Su Ryeon Seo ) 2014년

논문상세정보
인용/피인용
' Invited Mini Review : Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 생물학
  • alzheimersdisease(ad)
  • cerebral ischemia
  • neurodegeneration
  • parkinsonsdisease(pd)
  • pituitaryadenylatecyclase-activatingpolypeptide(pacap38)
  • traumaticbraininjury(tbi)
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
508 0

0.0%

' Invited Mini Review : Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases' 의 참고문헌

  • Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain trauma
    Delgado, M. FASEB J 17 : 1922 ~ 1924 - [2003]
  • VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair
    Waschek, J. A. Br. J. Pharmacol 169 : 512 ~ 523 - [2013]
  • Treadmill exercise inhibits traumatic brain injury- induced hippocampal apoptosis
    Kim, D. H. Physiol. Behav 101 : 660 ~ 665 - [2010]
  • Traumatic brain injury and recovery mechanisms: peptide modulation of periventricular neurogenic regions by the choroid plexus-CSF nexus
    Johanson, C. J. Neural. Transm 118 : 115 ~ 133 - [2011]
  • Transport of pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier and the prevention of ischemia-induced death of hippocampal neurons
    Banks, W. A. Ann. N. Y. Acad. Sci 805 : 270 ~ 277 - [1996]
  • The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides: in vivo metabolism of pituitary adenylate cyclase activating polypeptide-(1-38)
    Zhu, L. J. Biol. Chem 278 : 22418 ~ 22423 - [2003]
  • The neuroprotective effect of pituitary adenylate cyclase- activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32
    Vaudry, D. Proc. Natl. Acad. Sci. U. S. A 97 : 13390 ~ 13395 - [2000]
  • The neuropeptide PACAP promotes the α-secretase pathway for processing the Alzheimer amyloid precursor protein
    Kojro, E. FASEB J 20 : 512 ~ 514 - [2006]
  • The neuropeptide PACAP attenuates beta-amyloid (1-42)-induced toxicity in PC12 cells
    Onoue, S. Peptides 23 : 1471 ~ 1478 - [2002]
  • The epidemiology of traumatic brain injury: a review
    Bruns, J., Jr. Epilepsia 44 (Suppl 10) : 2 ~ 10 [2003]
  • The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics
    Hardy, J. Science 297 : 353 ~ 356 - [2002]
  • The PACAP receptor: Generation by alternative splicing of functional diversity among G protein-coupled receptors in nerve cells
    Journot, L. Semin. Cell Dev. Biol 5 : 263 ~ 272 [1994]
  • Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
    Plump, A. S. Cell 71 : 343 ~ 353 - [1992]
  • Role of PACAP in the physiology and pathology of the sympathoadrenal system
    Ghzili, H. Front Neuroendocrinol 29 : 128 ~ 141 - [2008]
  • Review on the protective effects of PACAP in models of neurodegenerative diseases In Vitro and In Vivo
    Reglodi, D. Curr. Pharm. Des 17 : 962 ~ 972 - [2011]
  • Regulation of pituitary adenylate cyclase activating polypeptide and its receptor type 1 after traumatic brain injury: comparison with brain-derived neurotrophic factor and the induction of neuronal cell death
    Skoglosa, Y. Neuroscience 90 : 235 ~ 247 - [1999]
  • Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP)
    Gottschall, P. E. Brain Res 637 : 197 ~ 203 - [1994]
  • Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: implications for early treatment of Alzheimer's disease
    Gozes, I. J. Neurobiol 33 : 329 ~ 342 - [1997]
  • Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide
    Uchida, D. Brain Res 736 : 280 ~ 286 - [1996]
  • Posttraumatic administration of pituitary adenylate cyclase activating polypeptide in central fluid percussion injury in rats
    Kovesdi, E. Neurotox. Res 13 : 71 ~ 78 - [2008]
  • Pituitary adenylate cyclase-activating polypeptide protects rat-cultured cortical neurons from glutamate-induced cytotoxicity
    Morio, H. Brain Res 741 : 82 ~ 88 - [1996]
  • Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts
    Gonzalez, B. J. Neuroscience 78 : 419 ~ 430 - [1997]
  • Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions
    Vaudry, D. Pharmacol. Rev 52 : 269 ~ 324 - [2000]
  • Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway
    Villalba, M. J. Neurosci 17 : 83 ~ 90 - [1997]
  • Pituitary adenylate cyclase-activating polypeptide (PACAP)/PAC1HOP1 receptor activation coordinates multiple neurotrophic signaling pathways: Akt activation through phosphatidylinositol 3-kinase gamma and vesicle endocytosis for neuronal survival
    May, V. J. Biol. Chem 285 : 9749 ~ 9761 - [2010]
  • Pituitary adenylate cyclase-activating polypeptide (PACAP) protects dorsal root ganglion neurons from death and induces calcitonin gene-related peptide (CGRP) immunoreactivity in vitro
    Lioudyno, M. J. Neurosci. Res 51 : 243 ~ 256 - [1998]
  • Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6
    Ohtaki, H. Proc. Natl. Acad. Sci. U. S. A 103 : 7488 ~ 7493 - [2006]
  • Pituitary adenylate cyclase-activating polypeptide (PACAP) 38 and PACAP4-6 are neuroprotective through inhibition of NADPH oxidase: potent regulators of microglia-mediated oxidative stress
    Yang, S. J. Pharmacol. Exp. Ther 319 : 595 ~ 603 - [2006]
  • Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study
    Hannibal, J. J. Comp. Neurol 453 : 389 ~ 417 - [2002]
  • Pituitary adenylate cyclase-activating peptide in sensory and autonomic ganglia: localization and regulation
    Sundler, F. Ann. N. Y. Acad. Sci 805 : 410 ~ 426 - [1996]
  • Pituitary adenylate cyclase- activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide
    Bourgault, S. Curr. Med. Chem 16 : 4462 ~ 4480 - [2009]
  • Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease
    Reglodi, D. Behav. Brain Res 151 : 303 ~ 312 - [2004]
  • Phosphatidylinositol 3'-OH kinase and protein kinase A pathways mediate the anti-apoptotic effect of pituitary adenylyl cyclase-activating polypeptide in cultured cerebellar granule neurons: modulation by ethanol
    Bhave, S. V. J. Neurochem 88 : 359 ~ 369 - [2004]
  • Pathophysiology of traumatic brain injury
    Werner, C. Br. J. Anaesth 99 : 4 ~ 9 - [2007]
  • Parkinson's disease: Clinical features and diagnosis
    Jankovic, J. J. Neurol. Neurosurg. Psychiatry 79 : 368 ~ 376 - [2008]
  • PACAP support of neuronal survival requires MAPK- and activity-generated signals
    Pugh, P. C Mol. Cell. Neurosci 31 : 586 ~ 595 - [2006]
  • PACAP protects neuronal differentiated PC12 cells against the neurotoxicity induced by a mitochondrial complex I inhibitor, rotenone
    Wang, G. FEBS Lett 579 : 4005 ~ 4011 - [2005]
  • PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis
    Vaudry, D. Eur. J. Neurosci 15 : 1451 ~ 1460 - [2002]
  • PACAP protects against salsolinol-induced toxicity in dopNeuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases Eun Hye Lee and Su Ryeon Seo http://bmbreports.org BMB Reports 375 aminergic SH-SY5Y cells: implication for Parkinson's disease
    Brown, D J. Mol. Neurosci 50 : 600 ~ 607 - [2013]
  • PACAP functions as a neurotrophic factor
    Arimura, A. Ann. N. Y. Acad. Sci 739 : 228 ~ 243 - [1994]
  • PACAP and a novel stable analog protect rat brain from ischemia: Insight into the mechanisms of action
    Dejda, A. Peptides 32 : 1207 ~ 1216 - [2011]
  • PAC1hop receptor activation facilitates catecholamine secretion selectively through 2-APB-sensitive Ca(2+) channels in PC12 cells
    Mustafa, T. Cell Signal 22 : 1420 ~ 1426 - [2010]
  • Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase- dependent mechanism in cerebellar granule cells
    Falluel-Morel, A. J. Neurochem 91 : 1231 ~ 1243 - [2004]
  • Novel stable PACAP analogs with potent activity towards the PAC1 receptor
    Bourgault, S. Peptides 29 : 919 ~ 932 - [2008]
  • Neurotrophic and neuroprotective effects of pituitary adenylate cyclase- activating polypeptide (PACAP) on mesencephalic dopaminergic neurons
    Takei, N. J. Neurosci. Res 54 : 698 ~ 706 - [1998]
  • Neurotoxicological and neuroprotective elements in Parkinson's disease
    Kostrzewa, R. M. Neurotox. Res 4 : 83 ~ 86 [2002]
  • Neuroprotective potential of three neuropeptides PACAP, VIP and PHI
    Dejda, A. Pharmacol. Rep 57 : 307 ~ 320 - [2005]
  • Neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) in MPP+-induced alteration of translational control in Neuro-2a neuroblastoma cells
    Deguil, J. J. Neurosci. Res 85 : 2017 ~ 2025 - [2007]
  • Neuroprotective effects of PACAP27 in mice model of Parkinson's disease involved in the modulation of K(ATP) subunits and D2 receptors in the striatum
    Wang, G. Neuropeptides 42 : 267 ~ 276 - [2008]
  • Neuroprotective effect of PACAP on translational control alteration and cognitive decline in MPTP parkinsonian mice
    Deguil, J. Neurotox. Res 17 : 142 ~ 155 - [2010]
  • Neuroprotective action of endogenous PACAP in cultured rat cortical neurons
    Shintani, N. Regul. Pept 126 : 123 ~ 128 - [2005]
  • Neuroprotection by endogenous and exogenous PACAP following stroke
    Chen, Y. Regul. Pept 137 : 4 ~ 19 - [2006]
  • Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice
    Rat, D. FASEB J 25 : 3208 ~ 3218 - [2011]
  • Neuropeptide PACAP inhibits hypoxic activation of brain microglia: a protective mechanism against microglial neurotoxicity in ischemia
    Suk, K. Brain Res 1026 : 151 ~ 156 - [2004]
  • Neuronal protection from apoptosis by pituitary adenylate cyclase-activating polypeptide
    Tanaka, J. Regul. Pept 72 : 1 ~ 8 - [1997]
  • Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration
    Waschek, J. A. Dev. Neurosci 24 : 14 ~ 23 - [2002]
  • Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats
    Reglodi, D. Regul. Pept 123 : 85 ~ 94 - [2004]
  • Molecular cloning and functional expression of rat cDNAs encoding the receptor for pituitary adenylate cyclase activating polypeptide (PACAP)
    Hosoya, M. Biochem. Biophys. Res. Commun 194 : 133 ~ 143 - [1993]
  • Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway
    Deumens, R. Exp. Neurol 175 : 303 ~ 317 - [2002]
  • Isolation of peptide transport system- 6 from brain endothelial cells: therapeutic effects with antisense inhibition in Alzheimer and stroke models
    Dogrukol-Ak, D. J. Cereb. Blood Flow Metab 29 : 411 ~ 422 - [2009]
  • Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells
    Miyata, A. Biochem. Biophys. Res. Commun 164 : 567 ~ 574 - [1989]
  • Involvement of Pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury
    Ziebell, J. M. Neurotherapeutics 7 : 22 ~ 30 - [2010]
  • Intracellular amyloid-beta in Alzheimer's disease
    LaFerla, F. M. Nat. Rev. Neurosci 8 : 499 ~ 509 - [2007]
  • Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide
    Armstrong, B. D. Neuroscience 151 : 63 ~ 73 - [2008]
  • Genes, proteins, and neurotoxins involved in Parkinson's disease
    von Bohlen und Halbach, O. Prog. Neurobiol 73 : 151 ~ 177 [2004]
  • Family-B G-protein-coupled receptors
    Harmar, A. J. Genome Biol 2 : 393.1 ~ 3013.10 [2001]
  • Exogenous administration of PACAP alleviates traumatic brain injury in rats through a mechanism involving the TLR4/MyD88/NF-κB pathway
    Mao, S. S. J. Neurotrauma 29 : 1941 ~ 1959 - [2012]
  • Evaluation of pharmacological treatment strategies in traumatic brain injury
    Marklund, N. Curr. Pharm. Des 12 : 1645 ~ 1680 - [2006]
  • Effects of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) on the spontaneous release of acetylcholine from the rat hippocampus by brain microdialysis
    Masuo, Y. Brain Res 611 : 207 ~ 215 - [1993]
  • Effects of combinatorial treatment with pituitary adenylate cyclase activating peptide and human mesenchymal stem cells on spinal cord tissue repair
    Fang, K. M. PLoS One 5 : e15299 ~ - [2010]
  • Effects of PACAP on the oxidative stress-induced cell death in chicken pinealocytes is influenced by the phase of the circadian clock
    Horvath, G. Neurosci. Lett 484 : 148 ~ 152 - [2010]
  • Effect of PACAP in central and peripheral nerve injuries
    Tamas, A. Int. J. Mol. Sci 13 : 8430 ~ 8448 - [2012]
  • Differential signal transduction by five splice variants of the PACAP receptor
    Spengler, D. Nature 365 : 170 ~ 175 - [1993]
  • Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat
    Reglodi, D. Stroke 31 : 1411 ~ 1417 - [2000]
  • Cytochrome c release and caspase activation in traumatic axonal injury
    Buki, A. J. Neurosci 20 : 2825 ~ 2834 - [2000]
  • Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease
    Wu, Z. L. Neurobiol. Aging 27 : 377 ~ 386 - [2006]
  • Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities
    Leker, R. R. Brain Res. Brain Res. Rev 39 : 55 ~ 73 - [2002]
  • Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection
    Chung, C. Y. Hum. Mol. Genet 14 : 1709 ~ 1725 - [2005]
  • Cell death mechanisms following traumatic brain injury
    Raghupathi, R. Brain Pathol 14 : 215 ~ 222 - [2004]
  • Biological relevance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the gastrointestinal tract
    Läuffer, J. M. Regul. Pepti 84 : 1 ~ 12 [1999]
  • BDNF mediates the neuroprotective effect of PACAP-38 on rat cortical neurons
    Frechilla, D. Neuroreport 12 : 919 ~ 923 - [2001]
  • Attenuation by PACAP of glutamate-induced neurotoxicity in cultured retinal neurons
    Shoge, K. Brain Res 839 : 66 ~ 73 - [1999]
  • Apurinic/apyrimidinic endonuclease APE1 is required for PACAP-induced neuroprotection against global cerebral ischemia
    Stetler, R. A. Proc. Natl. Acad. Sci. U. S. A 107 : 3204 ~ 3209 - [2010]
  • Apolipoprotein E and Alzheimer disease
    Strittmatter, W. J. Proc. Natl. Acad. Sci. U. S. A 92 : 4725 ~ 4727 - [1995]
  • Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man
    Gerlach, M J. Neural. Transm 103 : 987 ~ 1041 - [1996]
  • Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation
    Pantaloni, C. J. Biol. Chem 271 : 22146 ~ 22151 - [1996]
  • A non-cholinergic transmitter, pituitary adenylate cyclase-activating polypeptide, utilizes a novel mechanism to evoke catecholamine secretion in rat adrenal chromaffin cells
    Przywara, D. A. J. Biol. Chem 271 : 10545 ~ 10550 - [1996]